+ 1-971-202-1575 , TollFree:+ 1-800-910-6452
  [email protected]
Nerve Repair and Regeneration Market by Surgery [Direct Neuropathy by Type (Epineural Repair, Perineural Repair, and Group Fascicular Repair), Nerve Grafting by Type (Autografts, Allografts, and Xenografts), Neuromodulation Surgery (External and Internal), and Stem Cell Therapy] and Product [Biomaterial by Type (Nerve Conduits, Nerve Protectors, Nerve Wraps, and Nerve Connectors) and Neuromodulation Surgery Devices by Type (External by Type (Transcutaneous Electrical Nerve Stimulation and Transcranial Magnetic Stimulation) and Internal by Type (Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, and Others)]: Global Opportunity Analysis and Industry Forecast, 2017-2023
  • Published : May , 2017
  • |
  • Number of Pages : 150
  • |
  • Published By : Allied Market Research



Report Overview
Patients with serious nervous system injuries or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm shifting strategies are required to develop treatments for neurological injury. Early diagnosis and treatment can prevent complications and permanent injuries. The techniques of nerve repair and regeneration aid to cure the disorders such Alzheimer’s disease, Parkinson disease, and other neurological disorders.
The global nerve repair and regeneration market was valued at $5,927 million in 2016, and is estimated to garner $13,938  million by 2023, registering a CAGR of 13.0% from 2017 to 2023. The major factors that enhance the market growth are increase in geriatric population, rise in incidence of neurological & epidemic disorders, and launch of innovative products for nerve repair & regeneration. However, stringent regulatory requirements delay product approvals, thereby restraining the market growth.
The global nerve repair and regeneration market is segmented on the basis of surgery, product, and geography. Based on surgery, the market is classified into direct neuropathy, nerve grafting, neuromodulation surgery, and stem cell therapy. The neuromodulation surgeries segment contributed the highest share in 2016, owing to increase in patients suffering from neural disorders. Direct neuropathy is categorized into epineural repair, perineural repair, and group fascicular repair. Nerve grafting is subsegmented into autografts, allografts, and xenografts. Nerve modulation surgery is bifurcated into external and internal. By product, the market is divided into biomaterials and neuromodulation surgery devices. Neuromodulation surgery devices contributed the highest share in 2016, owing to the wide range of product offering for nerve repair. Biomaterial is classified into nerve conduits, nerve protectors, nerve wraps, and nerve connectors. Neuromodulation surgery devices is subsegmented into external and internal. External is further segmented into transcutaneous electrical nerve stimulation and transcranial magnetic stimulation. Internal is divided into spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, and others.
Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The North American market accounted for a significant share in 2016, owing to growth in number of patients suffering from neurological disorders.
KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the global nerve repair and regeneration market and the current trends & future estimations to elucidate the imminent investment pockets.
The report provides quantitative analysis of the industry from 2016 to 2023 to enable stakeholders to capitalize on the prevailing opportunities.
Extensive analysis of the market based on the surgeries and product elucidate the prevailing opportunities in these segments.
Comprehensive analysis of geographical regions is provided to determine the regional opportunities.
The key players operating in the market and their strategies are profiled to determine the competitive outlook of the market.

KEY MARKET SEGMENTS
By Surgery

Direct Neuropathy


Epineural Repair

Perineural Repair

Group Fascicular Repair


Nerve Grafting


Autografts

Allografts

Xenografts


Stem Cell Therapy
Neuromodulation Surgery


External Neuromodulation Surgery

Internal Neuromodulation Surgery



By Product

Biomaterials


Nerve Conduits

Nerve Protectors

Nerve Wraps

Nerve Connectors


Neuromodulation Surgery Devices


External Neuromodulation Surgery



Transcutaneous Electrical Nerve Stimulation

Transcranial Magnetic Stimulation




Internal Neuromodulation Surgery



Spinal Cord Stimulation

Deep Brain Stimulation

Sacral Nerve Stimulation

Vagus Nerve Stimulation

Others






By Geography

North America


U.S.

Canada

Mexico


Europe


UK

France

Germany

Italy

Spain

Rest of Europe


Asia-Pacific


Japan

China

India

Rest of Asia-Pacific


LAMEA


Latin America

Middle East

Africa



KEY PLAYERS PROFILED IN THE REPORT

AxoGen Inc. (U.S.)
Baxter International (U.S.)
Boston Scientific Incorporation (U.S.)
Cyberonics Inc. (U.S.)
Integra Lifesciences Corporation (U.S.)
Medtronic plc (U.S.)
Orthomed S.A.S. (France)
Polyganics B.V. (Netherlands)
St. Jude Medical (U.S.)
Stryker Corporation (U.S.)

OTHER PLAYERS IN THE VALUE CHAIN
(These players are not profiled in the report, but can be included on request)

Alafair Biosciences Inc.
Covidien Plc.
GlaxoSmithKline Pharmaceuticals Ltd.
NeuroMetrix, Inc.
Synapse Biomedical, Inc.
Convergent Technologies
Autonomic Technologies



Similar Market Studies

PUBLISHED REPORTS


UPCOMING REPORTS


Reports and Intelligence


We Accept

  • Stay Connected

Copyright ©2017 Reportsandintelligence All Rights Reserved